New poly(lactic-co-glycolic acid) derivatives: Modular polymers with tailored properties

Drug Discovery Today: Technologies

Volumn 2, Issue 1, 2005, Pages 7-13

  Dailey, Lea Ann ^a   Kissel, Thomas ^b  

^a NEKTAR THERAPEUTICS   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COPOLYMER; DNA VACCINE; GLUCAGON LIKE PEPTIDE 1; INSULIN; MACROGOL; NANOPARTICLE; PLASMID DNA; POLYGLACTIN; TETANUS TOXOID;

AEROSOL; ANTIBODY TITER; ARTICLE; BIODEGRADATION; CHEMICAL STRUCTURE; COLLOID; DIABETES MELLITUS; DRUG ADSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DNA INTERACTION; DRUG RELEASE; DRUG STABILITY; DRUG TARGETING; DRUG UPTAKE; EMULSION; GENE DELIVERY SYSTEM; HUMAN; HYDROPHILICITY; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM; MOLECULAR WEIGHT; NEBULIZER; SPRAY DRYING; STRUCTURE ACTIVITY RELATION; SUSPENSION; SUSTAINED RELEASE FORMULATION;

EID: 21744445247     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2005.05.017     Document Type: Review

References (63)

1. R. Jain et al. Controlled drug delivery by biodegradable poly(ester) devices: Different preparative approaches Drug Dev. Ind. Pharm. 24 1998 703-727
2. C. Matschke et al. Sustained-release injectables formed in situ and their potential use for veterinary products J. Control. Release 85 2002 1-15
3. D.T. O'Hagan et al. Microparticles for the delivery of DNA vaccines Immunol. Rev. 199 2004 191-200
4. M.L. Hedley Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors Expert Opin. Biol. Ther. 3 2003 903-910
5. M. Van der Weert et al. Protein instability in poly(lactide-co-glycolide) microparticles Pharm. Res. 17 2002 1159-1167
6. K. Fu et al. FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres J. Control. Release 58 1999 357-366
7. L.M. Sanders et al. Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: Influence of composition and molecular weight of polymer J. Pharm. Sci. 75 1986 356-360
8. T. Yasukawa et al. Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits Graefes Arch. Clin. Exp. Ophthalmol. 240 2002 672-678
9. S.P. Schwendeman Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems Crit. Rev. Ther. Drug Carrier Syst. 19 2002 73-98
10. C.H. Zheng et al A protein delivery system: Biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres Biochem. Biophys. Res. Commun. 323 2004 1321-1327
11. L. Liu et al. Pectin/poly(lactide-co-glycolide) composite matrices for biomedical applications Biomaterials 25 2004 3201-3210
12. E.L. Hedberg et al. In vivo degradation of porous poly(propylene fumarate)/poly(dl-lactic-co-glycolic acid) composite scaffolds Biomaterials 26 2005 4616-4623
13. N. Csaba et al. PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery Biomacromolecules 6 2005 271-278
14. Z. Wang et al. In vivo evaluation of a novel electrically conductive polypyrrole/poly(D,L-lactide) composite and polypyrrole-coated poly(D, L-lactide-co-glycolide) membranes J. Biomed. Mater. Res. A 70A 2004 28-38
15. C. Martinez-Sancho et al. Optimisation of aciclovir poly(D,L-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study Int. J. Pharm. 273 2004 45-56
16. S.D. Patil et al. Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control Diabetes Technol. Ther. 6 2004 887-897
17. M.N. Kumar et al. Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents J. Nanosci. Nanotechnol. 4 2004 990-994
18. L. Wang et al. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/ poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying Biomaterials 25 2004 3275-3282
19. A. Breitenbach et al. Branched biodegradable polyesters for parenteral drug delivery systems J. Control. Release 64 2000 167-178
20. M.L. Adams et al. Amphiphilic block copolymers for drug delivery J. Pharm. Sci. 92 2003 1343-1355
21. H. Otsuka et al. PEGylated nanoparticles for biological and pharmaceutical applications Adv. Drug Deliv. Rev. 55 2003 403-419
22. Kissel et al. ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly (ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins Adv. Drug Deliv. Rev. 54 2002 99-134
23. S. Chen et al. Triblock copolymers: Synthesis, characterization, and delivery of a model protein Int. J. Pharm. 288 2005 207-218
24. Y.M. Kwon et al. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition Pharm. Res. 21 2004 339-343
25. S. Choi et al. Control of blood glucose by novel GLP-1 delivery using biodegradable triblock copolymer of PLGA-PEG-PLGA in type 2 diabetic rats Pharm. Res. 21 2004 827-831
26. F. Ghana et al. Stent-based controlled release of intravascular angiostatin to limit plaque progression and in-stent restenosis J. Vasc. Interv. Radiol. 15 2004 601-608
27. J.H. Jeong et al. Biodegradable triblock copolymer of PLGA-PEG-PLGA enhances gene transfection efficiency Pharm. Res. 21 2004 50-54
28. P.Y. Lee et al. Thermosensitive hydrogel as a TGF-beta1 gene delivery vehicle enhances diabetic wound healing Pharm. Res. 20 2003 1995-2000
29. H.S. Yoo et al. Folate receptor targeted biodegradable polymeric doxorubicin micelles J. Control. Release 96 2004 273-283
30. J.D. Lathia et al. Polymeric contrast agent with targeting potential Ultrasonics 42 2004 763-768
31. J.J. Yoon et al. Immobilization of cell adhesive RGD peptide onto the surface of highly porous biodegradable polymer scaffolds fabricated by a gas foaming/salt leaching method Biomaterials 25 2004 5613-5620
32. H.S. Yoo et al. Hyaluronic acid modified biodegradable scaffolds for cartilage tissue engineering Biomaterials 26 2005 1925-1933
33. K.W. Chun et al. Biodegradable PLGA microcarriers for injectable delivery of chondrocytes: Effect of surface modification on cell attachment and function Biotechnol. Prog. 20 2004 1797-1801
34. A. Weissenbock et al. Binding and uptake of wheat germ agglutinin-grafted PLGA nanospheres by caco-2 monolayers Pharm. Res. 21 2004 1917-1923
35. A. Weissenbock et al. WGA-grafted PLGA-nanospheres: Preparation and association with caco-2 single cells J. Control. Release 99 2004 383-392
36. M. Bivas-Benita et al. PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium Eur. J. Pharm. Biopharm. 58 2004 1-6
37. A. Breitenbach et al. Biodegradable comb polyesters: Part I. Synthesis, characterization and structural analysis of poly(lactide) and poly(lactide-co-glycolide) grafted onto water-soluble poly(vinyl alcohol) as backbone Polymer 39 1998 3261-3271
38. A. Breitenbach et al. Biodegradable comb polyesters: Part II. Erosion and release properties of poly(vinyl alcohol)-g-poly(lactic-co-glycolic acid) Polymer 41 2000 4781-4792
39. K.F. Pistel et al. Brush-like branched biodegradable polyesters: Part III. Protein release from microspheres of poly (vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid) J. Control. Release 73 2001 7-20
40. T. Jung et al. Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres J. Control. Release 67 2000 157-169
41. T. Jung et al. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): Evaluation of antibody response after oral and nasal application in mice Pharm. Res. 18 2001 352-360
42. T. Jung et al. Loading of tetanus toxoid to biodegradable nanoparticles from branched poly(sulfobutyl-poly(vinyl alcohol)-g-(lactide-co-glycolide)) nanoparticles by protein adsorption: a mechanistic study Pharm. Res. 19 2002 1105-1113
43. Wittmar, M. et al. Fast degrading, high molecular weight, brush-like branched, amine-modified poly (vinyl alcohol)-graft-poly (D,L-lactide-co-glycolide)s as a platform for parenteral drug delivery systems: Synthesis, characterization and degradation behavior. Macromolecules (in press)
44. C.G. Oster et al. Design of amine-modified graft polyesters for the effective gene delivery using DNA loaded nanoparticles Pharm. Res. 21 2004 927-931
45. L.A. Dailey et al. The role of branched polyesters and their modifications in the development of modern drug delivery vehicles J. Control. Release 101 2005 137-149
46. P. Brandtzaeg et al. Mucosal immunity: A major adaptive defense mechanism Behring Inst. Mitt. 98 1997 1-23
47. M.A. Liu et al. DNA vaccines: A review J. Intern. Med. 253 2003 402-410
48. G. Otten et al. Induction of braod and potent anti-human immunodeficiency virus immune responses in rhesus macaques by priming with a DNA vaccine and boosting with protein-absorbed polylactide coglycolide microparticles J. Virol. 77 2003 6087-6092
49. E. Walter et al. Microencapsulation of DNA using poly (D,L-lactide-co-glycolide): Stability issues and release characteristics J. Control. Release 61 1999 361-374
50. A.M. Tinsley-Brown et al. Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery J. Control. Release 66 2000 229-241
51. L.A. Dailey et al. Nebulization of biodegradable nanoparticles: Impact on nebulizer technology and nanoparticle characteristics on aerosol features J. Control. Release 86 2003 131-144
52. L.A. Dailey et al. Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVA-g-PLGA Pharm. Res. 20 2003 2011-2020
53. S.P. Schwendemann Stability of proteins and their delivery from biodegradable polymer microspheres in: S. Cohen H. Bernstein (Eds.) Microparticulate Systems for the Delivery of Proteins and Vaccines 1996 Marcel Dekker 1-49
54. M. Simon et al. Self-assembling nanocomplexes from insulin and water-soluble branched polyesters, poly[(vinyl-3-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft-poly(L-lactic acid): A novel carrier for transmucosal delivery of peptides Bioconjug. Chem. 15 2004 841-849
55. A.C. Hunter et al. Therapeutic synthetic polymers: A game of Russian roulette? Drug Discov. Today 7 2002 998-1001
56. W.M. Pardridge Formulation of therapeutic synthetic polymers for drug and gene delivery Drug Discov. Today 7 2002 1120-1121
57. S.S. Davis Parenteral polymers Drug Discov. Today 7 2002 1159-1161
58. A. Bacon Polymers - a synthetic or natural choice? Drug Discov. Today 7 2002 1202-1203
59. M. Eaton Polymer therapeutics - what is missing? Drug Discov. Today 7 2002 1203-1204
60. R.O. Philipps Polymers for drug delivery: More research needed Drug Discov. Today 8 2003 17-18
61. G. Storm et al. Polymers for drug delivery: The debate continues Drug Discov. Today 8 2003 62
62. S. Brocchini Polymers in medicine; a game of chess Drug Discov. Today 8 2003 111-112
63. A.C. Hunter et al. Synthetic polymers in 21st century therapeutics: The way forward Drug Discov. Today 8 2003 154-156